Grants paid by Slc6a1 Connect
EIN 83-1415567 · Frisco, TX · Form 990, Schedule I · NTEE H80
Slc6a1 Connect of Frisco, TX (EIN 83-1415567) reported 21 grants paid totaling $1,751,483 to 11 recipients in tax years 2022–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,751,483
21 grants
Recipients
11
distinct organizations
Tax years
2022–2024
3 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 6 | $818,223 | — |
| 2023 | 8 | $668,980 | — |
| 2024 | 7 | $264,280 | — |
Top recipients
The 11 recipients receiving the most from Slc6a1 Connect, by grants paid, out of 11 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Nationwide Children's Hospital 01-0782751 | A | Columbus, OH | 4 | $1,189,787 | 2024 |
| Weill Cornell Medical Center 41-2237441 | A | New York, NY | 2 | $103,333 | 2023 |
| Children's Hospital of Colorado 84-0813462 | A | Aurora, CO | 2 | $102,040 | 2023 |
| University of Montana 81-0362989 | A | Missoula, MT | 2 | $81,024 | 2023 |
| University of Texas Southwestern 75-2556007 | A | Dallas, TX | 3 | $76,064 | 2024 |
| Gladstone Institutes 23-7203666 | A | San Francisco, CA | 2 | $50,000 | 2023 |
| University of Alabama 63-6001138 | A | Tuscaloosa, AL | 2 | $45,269 | 2024 |
| Vanderbilt University 62-0476822 | A | Nashville, TN | 1 | $35,000 | 2023 |
| American Society of Gene & Cell Therapy 91-1766321 | A | Waukesha, WI | 1 | $33,334 | 2024 |
| Combinedbrian Inc 83-1825692 | A | Brentwood, TN | 1 | $25,417 | 2024 |
| The Epilepsy Foundation 52-0856660 | A | Bowie, MD | 1 | $10,215 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 21 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | University of Colorado Aurora, CO | A | $106,740 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | Nationwide Children's Hospital Columbus, OH | A | $50,255 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | American Society of Gene & Cell Therapy Waukesha, WI | A | $33,334 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | University of Texas Southwestern Dallas, TX | A | $26,384 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | Combinedbrian Inc Brentwood, TN | A | $25,417 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | University of Alabama Tuscaloosa, AL | A | $11,935 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2024 | The Epilepsy Foundation Bowie, MD | A | $10,215 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202512469349301806 |
| 2023 | Nationwide Children's Hospital Columbus, OH | A | $393,411 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | Children's Hospital of Colorado Aurora, CO | A | $72,040 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | University of Montana Missoula, MT | A | $54,500 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | Vanderbilt University Nashville, TN | A | $35,000 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | University of Alabama Tuscaloosa, AL | A | $33,334 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | Weill Cornell Medical Center New York, NY | A | $33,333 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | Gladstone Institutes San Francisco, CA | A | $25,000 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2023 | University of Texas Southwestern Dallas, TX | A | $22,362 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202423189349307752 |
| 2022 | Nationwide Children's Hospital Columbus, OH | A | $639,381 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
| 2022 | Weill Cornell Medical Center New York, NY | A | $70,000 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
| 2022 | Children's Hospital of Colorado Aurora, CO | A | $30,000 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
| 2022 | University of Texas Southwestern Dallas, TX | A | $27,318 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
| 2022 | University of Montana Missoula, MT | A | $26,524 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
| 2022 | Gladstone Institutes San Francisco, CA | A | $25,000 | paid | THE PURPOSE OF THE GRANTS ARE TO ADVANCE SCIENTIFIC AND CLINICAL EFFORTS TO ADVANCE THE CURE OF SLC6A1. | 202311569349300621 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202512469349301806 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202423189349307752 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202311569349300621 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/831415567.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.